What is the maximum daily dose of Coreg (carvedilol) for hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Maximum Daily Dose of Carvedilol for Hypertension

The maximum daily dose of carvedilol for hypertension is 50 mg twice daily (100 mg total daily dose), though the controlled-release (CR) formulation can be dosed up to 80 mg once daily. 1, 2

Dosing Guidelines for Carvedilol in Hypertension

  • The initial dose of immediate-release carvedilol for hypertension is typically 6.25 mg twice daily 1
  • After 1-2 weeks, the dose can be increased to 12.5 mg twice daily if blood pressure remains uncontrolled 1
  • Further titration to 25 mg twice daily can be done if needed 1
  • The maximum recommended dose is 50 mg twice daily (100 mg total daily dose) 1
  • For controlled-release (CR) carvedilol, the maximum dose is 80 mg once daily 2, 3

Dosing Considerations

  • Carvedilol should be taken with food to reduce the risk of orthostatic hypotension 1
  • Dose titration should occur at intervals of at least 1-2 weeks to allow for full assessment of effects 1
  • In clinical trials, most patients achieved blood pressure control with 25-50 mg total daily dose 2
  • At 50 mg/day, carvedilol reduced sitting trough (12-hour) blood pressure by about 9/5.5 mm Hg 2

Formulation Differences

  • Immediate-release carvedilol requires twice-daily dosing 3
  • Controlled-release carvedilol allows for once-daily dosing with equivalent beta-blocking effects 3
  • Carvedilol CR 80 mg once daily is pharmacologically equivalent to immediate-release carvedilol 25 mg twice daily 4, 3
  • Carvedilol CR has been associated with fewer adverse events compared to immediate-release formulation (59.1% vs 77.5%) 3

Special Populations

  • Lower starting doses may be needed in elderly patients or those with hepatic impairment 1
  • Carvedilol has shown efficacy in patients with renal hypertension, with no significant changes in serum creatinine or blood urea nitrogen levels 5
  • Approximately one-third of patients in clinical trials required upward dose titration after 4 weeks due to inadequate response 6

Monitoring and Efficacy

  • Blood pressure response should be assessed at trough effect (24 hours after dosing for CR formulation, 12 hours for immediate-release) 1, 3
  • The peak antihypertensive effect occurs 1-2 hours after a dose 2
  • Trough-to-peak blood pressure response ratio is approximately 65% 2
  • Heart rate typically decreases by about 7.5 beats/minute at the 50 mg/day dose 2

Common Pitfalls to Avoid

  • Avoid abrupt discontinuation of carvedilol, which may lead to rebound hypertension or exacerbation of angina 1, 7
  • When switching from carvedilol to another antihypertensive (such as losartan), gradual tapering is recommended 7
  • Response may be smaller in Black patients compared to non-Black patients 2
  • Dose-related blood pressure response is accompanied by a dose-related increase in adverse effects 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Equivalent Dose of Metoprolol Succinate for 80 mg Carvedilol CR

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Switching from Beta Blocker to Losartan

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.